The 5th Galien Forum Event:
The 2014 Galien Forum will take place on the morning of October 28th, 2014, and will feature round table debates focusing on critical global healthcare issues and challenges.

Our annual life science Forum is rapidly becoming a leading event for discussing issues of innovation in the industry. The Galien Forum brings together leading CEOs, biomedical experts from industry, academia and government.
Alexandria Center™ for Life Science -
450 East 29th Street, 2nd Floor
(between 1st Avenue and the East River)
New York City -7:30 AM- 4:00 PM

The 8th Galien Awards Ceremony
The Prix Galien Awards, is considered the industry’s equivalent of the Nobel Prize, the highest accolade for biomedical research and innovation.

Each year our distinguished Awards Committee, selects among many candidates the best products competing in three categories – Best Pharmaceutical Agent, Best Biotechnology Product and Best Medical Technology approved by the FDA in the past five years.
American Museum of Natural History
Central Park West at 79th Street
New York City - 6:00 PM

Book online your seat at the prestigious
Awards Ceremony and your day pass to
attend the Galien Forum.

Please contact us at (212) 685-1592 or
by mail
Join the Galien Foundation !
By joining the Galien Foundation, you will become a valued part of an elite community committed to scientific innovation and the improvement of human health.

Membership offers you the opportunity to attend unique networking events, and contribute to the voice of scientific research by sharing your ideas with leaders in the industry, academia and government.

Package H SPECIAL OFFER NEW MEMBERS - Annual Individual Membership to the Galien Foundation. Includes one ticket to the Awards Ceremony and one Day Pass to the Galien Forum
Individual memberships are valid for one year, and membership dues are tax-deductible US $1,650.00

Package F Individual Day Pass to the Galien Forum US $750.00

Package G Individual ticket to the Awards Ceremony and one Day Pass to the Galien Forum US $2,125.00

Package E Individual ticket to Awards Ceremony US $1,750.00

Package I Online video 2013 forum website access US $75.00

I would like to reserve 1 pass/seat

Preliminary Program

-7:45 - 8:30: Introduction:
Chair: Dr. P.Roy Vagelos, Chairman of Regeneron Pharmaceuticals and retired Chairman and Chief Executive Officer at Merck & Co., Inc.
Keynote Speakers: Bert Vogelstein, Johns Hopkins School of Medicine.
Joel Marcus, Chairman A.R.E.
Neil de Crescenzo, General Manager, Oracle Health Sciences

-8:30 - 9:35: New Mechanisms for Industry-Academia Interactions: Successes and Obstacles
Chair: Dr. Michael Rosenblatt, Executive Vice-President and Chief Medical Officer, Merck & Co., Inc.
Dr. Christopher Austin, Director, National Center for Advancing Translational Sciences - National Institutes of Health
Pr. Michael S. Brown, Regental Professor, University of Texas, Southwestern Medical Center
Dr. Robert M Califf, Vice Chancellor for Clinical and Translational Medicine Duke University
Dr. John Thomas Potts Jr., Neuroendocrine Clinical Center, Harvard Medical School

- 9:35 - 10:40: Improving efficiency in drug development:
Chair: Dr. Mikael Dolsten, President Worldwide Research and Development, Pfizer,Inc.
Dr. Jeff Leiden, Chairman, President and CEO, Vertex
Dr. Jan Lundberg, Executive Vice President, Science and Technology and President, Lilly Research Labs, Lilly & Co.
Dr. Elliott Sigal, Former Executive Vice President, Chief Scientific Officer and President, R&D, BMS.

- 11:00 - 12:05: Personalized medicine, Effect on drug R&D
Chair: Pr. Joseph Goldstein, Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center at Dallas
Dr. David Altshuler, Massachusetts General Hospital and Broad Institute
Dr. Richard Lifton, Yale University School of Medicine
Dr. Jonathan Sheldon, Global Senior Director of Translational Medicine, Oracle Health Sciences.
Dr. Bert Vogelstein, Johns Hopkins School of Medicine
Dr. Huda Zoghbi, Baylor College of Medicine

Sponsored by Oracle Lifesciences.

-12:45 - 1:50: Affordable Care Act. US Healthcare in Transition: The Stakes for Industry
Chair: Dr. P. Roy Vagelos
Ken Frazier, Chairman, CEO and President, Merck & Co., Inc.
Alex Gorsky, Chairman and CEO, Johnson&Johnson
John Lechleiter, Chairman and CEO, Eli Lilly & Company

-1:50 - 2:55: Neurodegenerative Disease Drug Progress
Chair: Pr. Marc Tessier-Lavigne, President, The Rockefeller University, New York, Professor Laboratory of Brain Development and Repair
Dr. Samantha Budd, Vice President, Neuroscience iMed at AstraZeneca R&D.
Dr. David Holtzman, Andrew B. and Gretchen P. Jones Professor and Chairman of Neurology, Professor of Developmental Biology, Associate Director of the Alzheimer's Disease Research Center . Washington University.
Dr. Morgan Sheng, Vice President, Neuroscience, Genentech Inc.
Dr. Reisa Sperling ( tbc) , Professor of Neurology at Harvard Medical School Department of Neurology, Brigham and Women's Hospital.

Sponsored by Alexandria Real Estate

-2:55 - 4:00: Oncology: Newer Therapies:
Chair: Dr. Paul A. Marks, Laboratory Head of Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, President, Emeritus, MSKCC
Herve Hoppenot, President, Novartis Oncology. Novartis Pharmaceuticals Corporation
Dr. Carl H. June, Director of Translational Research at the Abramson Cancer Center at the University of Pennsylvania
Mark Kris, Chief, Thoracic Oncology Services, Memorial Sloan-Kettering Cancer Center
Dr. Ira Mellman, Vice-President, Research Oncology, Genentech

Special dietary requirements

Enter your details